SEC Form 4 · accession 0001645627-17-000115
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 11:04 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 5, 2017 | P | 11,000 | $0.0258 | A | 23,085,189 | D | |
| Common Stock | Sep 5, 2017 | P | 2,000 | $0.0259 | A | 23,087,189 | D | |
| Common Stock | Sep 5, 2017 | P | 3,000 | $0.0259 | A | 23,090,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0258 | A | 23,095,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0258 | A | 23,100,189 | D | |
| Common Stock | Sep 5, 2017 | P | 10,000 | $0.0259 | A | 23,110,189 | D | |
| Common Stock | Sep 5, 2017 | P | 10,000 | $0.0259 | A | 23,120,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0258 | A | 23,125,189 | D | |
| Common Stock | Sep 5, 2017 | P | 5,000 | $0.0259 | A | 23,130,189 | D |
Table II — derivative securities
No Table II lines on this filing.